Sharad Verma

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Research Output 1997 2018


EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Pietra, A. D., LaFrance, L. V., Mellinger, M., Duquenne, C., Tian, X., Kruger, R. G., McHugh, C. F., Miller, W. H., Dhanak, D., Verma, S., Tummino, P. J., Creasy, C. L., Graves, A. P. & 1 others, Diaz, E., Dec 6 2012, In : Nature. 492, 7427, p. 108-112 5 p.

Research output: Contribution to journalLetter

Lymphoma, Large B-Cell, Diffuse
Polycomb Repressive Complex 2
Follicular Lymphoma